Skip to main content

Table 2 The proportion of Child-Pugh class B patients at baseline in studies

From: Efficacy and safety of oral branched-chain amino acid supplementation in patients undergoing interventions for hepatocellular carcinoma: a meta-analysis

Study BCAA Control Total  
Nishikawa et al. 2013 30/115 26 % 52/141 37 % 82/256 32 % **
Kanekawa et al. 2014 26/49 53 % 13/43 30 % 39/92 42 % **
Takeda et al. 2014 18/33 55 % 14/44 32 % 32/77 42 % **
Kuroda et al. 2010 11/20 55 % 8/15 53 % 19/35 54 % **
Nagasue et al. 1998 13/67 19 % 14/65 22 % 27/132 20 % *
Meng et al. 1999 4/21 19 % 3/24 13 % 7/45 16 % *
Ichikawa et al. 2013 5/26 19 % 5/30 17 % 10/56 18 % *
Okabayashi et al. 2008 7/40 18 % 10/72 14 % 17/112 15 % *
  1. **: Study that reported significantly lower mortality in the BCAA group compared with the control group
  2. *: Study that reported no significant difference in mortality between the two groups